Breaking News

CIT Acquires LAB Research

Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), has acquired the assets of LAB Research, Inc., consisting of three facilities located in Canada, Denmark and Hungary.

Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), has acquired the assets of LAB Research, Inc., consisting of three facilities located in Canada, Denmark and Hungary.

The newly created CIT-LAB group will have consolidated sales of $103 million and 830 staff across five sites in France (Evreux and Saint-Nazaire), Canada (Laval), Denmark (Lille Skensved) and Hungary (Veszprém). The financial details were not disclosed.

CIT has more than 40 years of experience providing preclinical contract research. The CIT-LAB group expands services in North America with LAB Research’s facilities in Canada. The Scandinavian and Central Europe facilities are also a key asset and will allow closer support for more customers.

“With the acquisition of Lab Research, we seized a major opportunity to create a global player serving the pharmaceutical, biotechnology and chemical industries. At a time when the biggest industry companies are turning to global outsourcing agreements, the new CIT-LAB group will be a partner of choice thanks to its ability to carry out a broader range of studies and to provide scientific synergies between facilities,” said Dr. Jean-François Le Bigot, CIT and ABC executive chairman.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters